US AGs dismiss $18B bid to resolve opioid lawsuit - report - Breaking The News
Download our appPlay StoreApp Store

US AGs dismiss $18B bid to resolve opioid lawsuit - report

Attorneys general of 21 American states, along with Puerto Rico and the District of Columbia, dismissed the $18 billion proposal by McKesson Corp., AmerisourceBergen Corp. and Cardinal Health Inc. to settle the legal process over their alleged involvement in the opioid crisis, the Wall Street Journal reported on Friday, citing the letter the AGs sent to the pharmaceutical wholesale companies.

Another source related to the matter told the newspaper that the states want a payment of $22 billion-$32 billion from the three drug distributors to reach a settlement in the legal case. The payment of $18 billion was reportedly meant to be spread over 18 years.

In October 2019, the three companies reached a $215 million settlement with two counties in the state of Ohio.

Related News
Purdue Pharma owners to pay up to $7.4B in opioid settlement
New York Attorney General Letitia James announced on Thursday that the Sackler family members, who own the OxyContin maker Purdue Pharma, reached a settlement to pay up to $7.4 billion "for their instrumental role in creating the opioid crisis."According to the new settlement, the Purdue Pharma owners will contribute up to $7.4 billion over the span of 15 years, with a portion of the money going to the victims of the opioid crisis. The first payment of $1.5...
J&J to pay $149.5M to settle Washington state opioid case
Washington state Attorney General Bob Ferguson announced on Wednesday that Johnson & Johnson agreed to pay $149.5 million to settle the state's lawsuit, which alleged the company participated in "fueling the opioid epidemic." Under the settlement, $123.3 million of the total sum will be used to combat the opioid crisis. "Today's resolution, filed in King County Superior Court, provides Washington and its local governments with tens of millions of dollars more to...
Emergent Biosolutions soars 16% after FDA panel call
Emergent BioSolutions Inc.'s shares surged over 16% in extended trading on Wednesday after advisory committees for the United States Food and Drug Administration recommended selling its nasal spray Narcan over the counter. The spray is a "treatment of known or suspected opioid overdose, as manifested by respiratory and/or central nervous system depression," according to the FDA, which is expected to announce its final formal decision on...
Elliott Management holds large position in Cardinal Health
Elliott Management has a large position in Cardinal Health Inc. and is seeking more seats on its board, the Wall Street Journal reported Monday, citing people familiar with the matter. According to the report, Elliott named five directors to the 11-person board about two weeks ago before Cardinal abruptly replaced its CEO last week. The new moves would determine whether the management change at Cardinal could help boost the company's share price. Cardinal...

Please observe our Terms of Use. The price information is time delayed to varying extents, but as a rule by 15 minutes or more, according to the regulations of the selected stock exchange and/or licensors and the type of securities.

© 2025 TeleTrader Software GmbH. All rights reserved

This website uses cookies to ensure you get the best experience. Our Terms of Use and Data Protection Policy explain the data we collect, why we collect them, and how we may share them.